Neurocrine Biosciences Inc [NBIX]
$85.71 2.80 (3.16%)
Market Cap 8.08 Billion
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.
EPS -1.12 P/E Ratio 819.73
Previous Earnings Mon, Apr 29, 2019
Latest Earnings Mon, Jul 29, 2019 (In 9 days)
|Symbol||Price||Day %||YTD %|
This list of trending stocks may change throughout the trading day.